Home - Melanoma Research Alliance

MRA 2019-2020 Request for Proposals - Now Available

The Melanoma Research Alliance (MRA) is pleased to announce its 2019 – 2020 Request for Proposals for preclinical, translational and early clinical research with the power to transform melanoma prevention, detection, staging, and treatment.

The 2018 - 2019 award cycle is anticipated to support at least $9 million in funding. Proposals will be accepted for Pilot, Team Science, Young Investigator, and Mid-Career Awards.

Acral Melanoma & Adjuvant Therapy – One Patient’s Decision

When David was diagnosed with Stage 3 acral melanoma he faced a major decision. The surgery to remove it was successful - but should he move forward with adjuvant therapy to reduce the risk of it returning? Learn more about the benefits - and risks - of this approach and read what David decided.

Resisting Resistance

For too many patients, the incredible responses they experience from targeted and immunotherapies don't last. Resistance is a real challenge. At the MRA 2019 Scientific Retreat, several researchers reported on research funded by MRA to identify new ways to combat drug resistance, including a number of strategies that are already being tested in the clinic.

Fighting For Her Life with a Clinical trial

Colleen Wittoesch was a regular volunteer at MD Anderson Cancer Center. She came to the hospital every week to help out and spend time with patients and families in the melanoma clinic for going on seven years. Little did she know that in 2016 she too would walk through the clinic doors as a patient.